Lorlatinib is a really new kind of medicine. It’s specifically for a type of lung cancer called NSCLC, and it’s made for people whose cancer has already been treated with other ALK inhibitors and got worse. This medicine hits two different cancer-related proteins, ALK and ROS1, to help slow down tumor growth.
There are two sizes of Lorlatinib tablets: 25 mg and 100 mg, and both of them are covered with a special film. The doctors say to take the big 100 mg pill of Lorlatinib once each day. It’s fine whether you have it with a meal or not.
Each bottle holds a bunch of the pills — exactly 30 to be precise. Since it’s like the latest generation, this stuff could be a good option if other ALK haven’t worked out for someone.
Reviews
There are no reviews yet.